View in EDS HTML Full Text PDF Full Text

Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.

Saved in:
Bibliographic Details
Title: Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Authors: Perez, Edith A.1 (AUTHOR) perez.edith@mayo.edu, Barrios, Carlos2 (AUTHOR), Eiermann, Wolfgang3 (AUTHOR), Toi, Masakazu4 (AUTHOR), Im, Young‐Hyuck5 (AUTHOR), Conte, Pierfranco6,7 (AUTHOR), Martin, Miguel8 (AUTHOR), Pienkowski, Tadeusz9 (AUTHOR), Pivot, Xavier B.10 (AUTHOR), Burris, Howard A.11 (AUTHOR), Petersen, Jennifer A.12 (AUTHOR), De Haas, Sanne13 (AUTHOR), Hoersch, Silke13 (AUTHOR), Patre, Monika13 (AUTHOR), Ellis, Paul Anthony14 (AUTHOR), Im, Young-Hyuck15 (AUTHOR), Burris, Howard A 3rd16 (AUTHOR)
Source: Cancer (0008543X). Nov2019, Vol. 125 Issue 22, p3974-3984. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0008543X
DOI:10.1002/cncr.32392